Skip to content

Neoadjuvant low-dose radiotherapy in the treatment of spinal chordoma: a randomized controlled trial

Neoadjuvant low-dose radiotherapy in the treatment of spinal chordoma: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020658
Enrollment
Unknown
Registered
2019-01-12
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal chordoma

Interventions

radiotherapy group:low dose radiotherapy followed by surgery

Sponsors

Department of Orthopedic Oncology, Changzheng Hospital, Navy Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. pathological diagnosed spinal chordoma; 2. Aged 18-65 years; 3. without spinal cord compression; 4. without local radiotherapy history; 5. tolerate radiotherapy and surgery.

Exclusion criteria

Exclusion criteria: 1. with spinal cord compression; 2. with local radiotherapy history; 3. could not tolerate radiotherapy or surgery.

Design outcomes

Primary

MeasureTime frame
local recurrence rate;survival rate;

Secondary

MeasureTime frame
Neurological status;Quality of life;

Countries

China

Contacts

Public ContactJianru Xiao

Department of Orthopedic Oncology, Changzheng Hospital, Navy Medical University

jianruxiao83@163.com+86 13701785283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026